Vermillion & White Wealth Management Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.15K | Buy |
+6,500
| New | +$6.15K | ﹤0.01% | 347 |
|
|
2025
Q1 | – | Sell |
-13,415
| Closed | -$9.91K | – | 544 |
|
|
2024
Q4 | $9.91K | Hold |
13,415
| – | – | 0.01% | 235 |
|
|
2024
Q3 | $21.1K | Buy |
13,415
+1,000
| +8% | +$1.57K | 0.02% | 178 |
|
|
2024
Q2 | $20.9K | Hold |
12,415
| – | – | 0.02% | 181 |
|
|
2024
Q1 | $29.8K | Buy |
+12,415
| New | +$29.8K | 0.02% | 154 |
|